During the past decade, STAAMP Research conducted 7 clinical trials. In the 10-year time frame, 7 clinical trials started and 1 clinical trials were completed, i.e. on average, 14.3% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 1 clinical trials were completed. i.e. 25% of trials that started reached the finish line.

Out of the total clinical trials conducted in "STAAMP Research" #1 sponsor was "Optinose US Inc." with 2 trials, followed by "Regeneron Pharmaceuticals" with 2 trials sponsored, "DBV Technologies" with 1 trials sponsored, "Gilead Sciences" with 1 trials sponsored and "Pfizer" with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "STAAMP Research" #1 collaborator was "Sanofi" with 2 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "STAAMP Research" are "Asthma" (1 trials), "Bilateral Nasal Polyposis" (1 trials), "COVID-19" (1 trials), "Chronic Rhinosinusitis" (1 trials) and "Chronic Rhinosinusitis (CRS) With and Without Nasal Polyps" (1 trials). Many other conditions were trialed in "STAAMP Research" in a lesser frequency.

Most popular intervention types in "STAAMP Research" are "Drug" (6 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "DUPIXENT®" (2 trials), "OPN-375" (2 trials), "Matching placebo" (1 trials), "Placebo" (1 trials) and "Placebo to Match RDV" (1 trials). Other intervention names were less common.

The vast majority of trials in "STAAMP Research" are 7 trials for "All" genders.

Currently, there are NaN active trials in "STAAMP Research". undefined are not yet recruiting, 4 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in STAAMP Research, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in STAAMP Research, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".